120 related articles for article (PubMed ID: 18404570)
1. Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluation.
Bonache MC; Quesada E; Sheen CW; Balzarini J; Sluis-Cremer N; Pérez-Pérez MJ; Camarasa MJ; San-Félix A
Nucleosides Nucleotides Nucleic Acids; 2008 Apr; 27(4):351-67. PubMed ID: 18404570
[TBL] [Abstract][Full Text] [Related]
2. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
3. 4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family.
Lobatón E; Velázquez S; San-Félix A; De Clercq E; Balzarini J; Camarasa MJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):711-4. PubMed ID: 11563098
[TBL] [Abstract][Full Text] [Related]
4. Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues.
Velázquez S; Alvarez R; Pérez C; Gago F; De Clercq E; Balzarini J; Camarasa MJ
Antivir Chem Chemother; 1998 Nov; 9(6):481-9. PubMed ID: 9865386
[TBL] [Abstract][Full Text] [Related]
5. Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.
Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Barrios FR; Gago F; Camarasa MJ; San-Félix A
J Med Chem; 2005 Oct; 48(21):6653-60. PubMed ID: 16220981
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro activity of novel N-3 acylated TSAO-T compounds against HIV-1 and HCV.
Moura M; Josse S; Nguyen Van Nhien A; Fournier C; Duverlie G; Castelain S; Soriano E; Marco-Contelles J; Balzarini J; Postel D
Eur J Med Chem; 2011 Oct; 46(10):5046-56. PubMed ID: 21880398
[TBL] [Abstract][Full Text] [Related]
7. "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains.
Lobatón E; Velázquez S; Pérez-Pérez MJ; Jimeno ML; San-Félix A; De Clercq E; Balzarini J; Camarasa MJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):707-10. PubMed ID: 11563097
[TBL] [Abstract][Full Text] [Related]
8. Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.
de Castro S; García-Aparicio C; Van Laethem K; Gago F; Lobatón E; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
Antiviral Res; 2006 Aug; 71(1):15-23. PubMed ID: 16616962
[TBL] [Abstract][Full Text] [Related]
9. Novel series of [ddN]-[TSAO-T] heterodimers as potential bi-functional inhibitors of HIV-1 RT. Studies in the linker and ddN region.
Velázquez S; Tuñón V; Jimeno ML; Pérez-Pérez MJ; San-Félix A; Chamorro C; Lobatón E; Esteban-Gamboa A; De Clercq E; Balzarini J; Camarasa MJ
Nucleosides Nucleotides; 1999; 18(4-5):1029-30. PubMed ID: 10432737
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-HIV-1 activity of novel TSAO-T derivatives modified at the 2'- and 5'-positions of the sugar moiety.
Ingate S; Pérez-Pérez MJ; De Clercq E; Balzarini J; Camarasa MJ
Antiviral Res; 1995 Jun; 27(3):281-99. PubMed ID: 8540750
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives.
Chamorro C; Pérez-Pérez MJ; Rodríguez-Barrios F; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
Antiviral Res; 2001 Jun; 50(3):207-22. PubMed ID: 11397508
[TBL] [Abstract][Full Text] [Related]
12. First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication.
Nguyen Van Nhien A; Tomassi C; Len C; Marco-Contelles JL; Balzarini J; Pannecouque C; De Clercq E; Postel D
J Med Chem; 2005 Jun; 48(13):4276-84. PubMed ID: 15974581
[TBL] [Abstract][Full Text] [Related]
13. Hybrids of [TSAO-T]-[foscarnet]: The first conjugate of foscarnet with a non-nucleoside reverse transcriptase inhibitor through a labile covalent ester bond.
Velázquez S; Lobatón E; De Clercq E; Koontz DL; Mellors JW; Balzarini J; Camarasa MJ
J Med Chem; 2004 Jun; 47(13):3418-26. PubMed ID: 15189038
[TBL] [Abstract][Full Text] [Related]
14. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.
de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482
[TBL] [Abstract][Full Text] [Related]
15. N-3 substituted TSAO derivatives as a probe to explore the dimeric interface of HIV-1 reverse transcriptase.
Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Camarasa MJ; San-Félix A
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):947-9. PubMed ID: 14565318
[No Abstract] [Full Text] [Related]
16. Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.
Rodríguez-Barrios F; Pérez C; Lobatón E; Velázquez S; Chamorro C; San-Félix A; Pérez-Pérez MJ; Camarasa MJ; Pelemans H; Balzarini J; Gago F
J Med Chem; 2001 Jun; 44(12):1853-65. PubMed ID: 11384232
[TBL] [Abstract][Full Text] [Related]
17. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3' '-substituted TSAO derivatives with anti-HIV-1 and anti-HIV-2 activity through an efficient palladium-catalyzed cross-coupling approach.
Lobatón E; Rodríguez-Barrios F; Gago F; Pérez-Pérez MJ; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2002 Aug; 45(18):3934-45. PubMed ID: 12190315
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5' '-(4' '-amino-1' ',2' '-oxathiole-2' ',2' '-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization.
Sluis-Cremer N; Hamamouch N; San Félix A; Velazquez S; Balzarini J; Camarasa MJ
J Med Chem; 2006 Aug; 49(16):4834-41. PubMed ID: 16884295
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
Velázquez S; Alvarez R; San-Félix A; Jimeno ML; De Clercq E; Balzarini J; Camarasa MJ
J Med Chem; 1995 May; 38(10):1641-9. PubMed ID: 7538589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
